|
|
News Breaks | | | | October 18, 2012 | | 07:40 EDT |  | PBTH | Prolor Biotech to present positive data on hGH-CTP
Prolor Biotech announced that researchers will present data that confirm that hGH-CTP has the potential to be administered once weekly to adults with growth hormone deficiency and that it appears to be safe and well tolerated. The data to be presented include results from the company's Phase II trial, which affirm that a single weekly injection of hGH-CTP has the potential to replace seven consecutive daily injections of currently marketed human growth hormone. These results enabled Prolor to proceed with plans for a Phase III trial in growth hormone deficient adults, which is expected to commence in the coming months. | |
|
News For PBTH From The Last 14 Days Check below for free stories on PBTH the last two weeks. |
|
|
| There are no results for PBTH |
|
|
|
|
|
|
